Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study

Michael J. Englesbe; Alice Moyer; Dean Y. Kim; Darla K. Granger; Richard Pietroski; Atsushi Yoshida; Juan D. Arenas; Henry Oh; Shawn J. Pelletier; Darrell A. Campbell; Jeffrey D. Punch; John C. Magee; Scott A. Gruber; Randall S. Sung

doi:10.1097/01.tp.0000225764.21343.e3

Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study

Michael J. Englesbe, Alice Moyer, Dean Y. Kim, Darla K. Granger, Richard Pietroski, Atsushi Yoshida, Juan D. Arenas, Henry Oh, Shawn J. Pelletier, Darrell A. Campbell, Jeffrey D. Punch, John C. Magee, Scott A. Gruber, Randall S. Sung

Research output: Contribution to journal › Article › peer-review

45 Scopus citations

Abstract

Little is known about the use of histidine-tryptophan-ketoglutarate (HTK) preservation solution for pancreas preservation. We compared early pancreas graft outcomes at four pancreas transplant programs within the state of Michigan in 2002 and 2003 (University of Wisconsin [UW] era) with those in 2004 (HTK era). The primary endpoint was early graft loss. The UW group (n=41) and the HTK group (n=36) had similar outcomes with respect to: technical graft loss (9.8% vs. 8.3%, P=NS), 90-day graft function (90.2% vs. 86.1%, P=NS), and rate of pancreatic leak/abscess (12.2% vs. 11.1%, P=NS). There were also no significant differences in postoperative amylase and lipase levels between the two groups. The HTK group did have significantly more acute rejection within the first 180 days (25.0% vs. 9.8%, P<0.05). HTK is a suitable substitute for UW in the preservation of pancreas allografts.

Original language	English (US)
Pages (from-to)	136-139
Number of pages	4
Journal	Transplantation
Volume	82
Issue number	1
DOIs	https://doi.org/10.1097/01.tp.0000225764.21343.e3
State	Published - Jul 2006

Keywords

Clinical transplantation
Complications of clinical transplantation
Histidine-tryptophan-ketoglutarate (HTK)
Organ preservation
Pancreas
Surgical

ASJC Scopus subject areas

Transplantation

Access to Document

10.1097/01.tp.0000225764.21343.e3

Cite this

Englesbe, M. J., Moyer, A., Kim, D. Y., Granger, D. K., Pietroski, R., Yoshida, A., Arenas, J. D., Oh, H., Pelletier, S. J., Campbell, D. A., Punch, J. D., Magee, J. C., Gruber, S. A., & Sung, R. S. (2006). Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study. Transplantation, 82(1), 136-139. https://doi.org/10.1097/01.tp.0000225764.21343.e3

Englesbe, MJ, Moyer, A, Kim, DY, Granger, DK, Pietroski, R, Yoshida, A, Arenas, JD, Oh, H, Pelletier, SJ, Campbell, DA, Punch, JD, Magee, JC, Gruber, SA & Sung, RS 2006, 'Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study', Transplantation, vol. 82, no. 1, pp. 136-139. https://doi.org/10.1097/01.tp.0000225764.21343.e3

@article{d12491fa10c54e75a05b49507434d9ce,

title = "Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study",

abstract = "Little is known about the use of histidine-tryptophan-ketoglutarate (HTK) preservation solution for pancreas preservation. We compared early pancreas graft outcomes at four pancreas transplant programs within the state of Michigan in 2002 and 2003 (University of Wisconsin [UW] era) with those in 2004 (HTK era). The primary endpoint was early graft loss. The UW group (n=41) and the HTK group (n=36) had similar outcomes with respect to: technical graft loss (9.8% vs. 8.3%, P=NS), 90-day graft function (90.2% vs. 86.1%, P=NS), and rate of pancreatic leak/abscess (12.2% vs. 11.1%, P=NS). There were also no significant differences in postoperative amylase and lipase levels between the two groups. The HTK group did have significantly more acute rejection within the first 180 days (25.0% vs. 9.8%, P<0.05). HTK is a suitable substitute for UW in the preservation of pancreas allografts.",

keywords = "Clinical transplantation, Complications of clinical transplantation, Histidine-tryptophan-ketoglutarate (HTK), Organ preservation, Pancreas, Surgical",

author = "Englesbe, {Michael J.} and Alice Moyer and Kim, {Dean Y.} and Granger, {Darla K.} and Richard Pietroski and Atsushi Yoshida and Arenas, {Juan D.} and Henry Oh and Pelletier, {Shawn J.} and Campbell, {Darrell A.} and Punch, {Jeffrey D.} and Magee, {John C.} and Gruber, {Scott A.} and Sung, {Randall S.}",

year = "2006",

month = jul,

doi = "10.1097/01.tp.0000225764.21343.e3",

language = "English (US)",

volume = "82",

pages = "136--139",

journal = "Transplantation",

issn = "0041-1337",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation

T2 - A multicenter study

AU - Englesbe, Michael J.

AU - Moyer, Alice

AU - Kim, Dean Y.

AU - Granger, Darla K.

AU - Pietroski, Richard

AU - Yoshida, Atsushi

AU - Arenas, Juan D.

AU - Oh, Henry

AU - Pelletier, Shawn J.

AU - Campbell, Darrell A.

AU - Punch, Jeffrey D.

AU - Magee, John C.

AU - Gruber, Scott A.

AU - Sung, Randall S.

PY - 2006/7

Y1 - 2006/7

N2 - Little is known about the use of histidine-tryptophan-ketoglutarate (HTK) preservation solution for pancreas preservation. We compared early pancreas graft outcomes at four pancreas transplant programs within the state of Michigan in 2002 and 2003 (University of Wisconsin [UW] era) with those in 2004 (HTK era). The primary endpoint was early graft loss. The UW group (n=41) and the HTK group (n=36) had similar outcomes with respect to: technical graft loss (9.8% vs. 8.3%, P=NS), 90-day graft function (90.2% vs. 86.1%, P=NS), and rate of pancreatic leak/abscess (12.2% vs. 11.1%, P=NS). There were also no significant differences in postoperative amylase and lipase levels between the two groups. The HTK group did have significantly more acute rejection within the first 180 days (25.0% vs. 9.8%, P<0.05). HTK is a suitable substitute for UW in the preservation of pancreas allografts.

AB - Little is known about the use of histidine-tryptophan-ketoglutarate (HTK) preservation solution for pancreas preservation. We compared early pancreas graft outcomes at four pancreas transplant programs within the state of Michigan in 2002 and 2003 (University of Wisconsin [UW] era) with those in 2004 (HTK era). The primary endpoint was early graft loss. The UW group (n=41) and the HTK group (n=36) had similar outcomes with respect to: technical graft loss (9.8% vs. 8.3%, P=NS), 90-day graft function (90.2% vs. 86.1%, P=NS), and rate of pancreatic leak/abscess (12.2% vs. 11.1%, P=NS). There were also no significant differences in postoperative amylase and lipase levels between the two groups. The HTK group did have significantly more acute rejection within the first 180 days (25.0% vs. 9.8%, P<0.05). HTK is a suitable substitute for UW in the preservation of pancreas allografts.

KW - Clinical transplantation

KW - Complications of clinical transplantation

KW - Histidine-tryptophan-ketoglutarate (HTK)

KW - Organ preservation

KW - Pancreas

KW - Surgical

UR - http://www.scopus.com/inward/record.url?scp=33747465871&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33747465871&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000225764.21343.e3

DO - 10.1097/01.tp.0000225764.21343.e3

M3 - Article

C2 - 16861954

AN - SCOPUS:33747465871

SN - 0041-1337

VL - 82

SP - 136

EP - 139

JO - Transplantation

JF - Transplantation

IS - 1

ER -

Early pancreas transplant outcomes with histidine-tryptophan-ketoglutarate preservation: A multicenter study

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this